Prospective Observational Study on Individualized Treatment with IsaVuconazole in Eastern Japan:KSGCT multicenter study

Prospective Observational Study on Individualized Treatment with IsaVuconazole in Eastern Japan: KSGCT multicenter study - POSITIVE-J study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059113

Enrollment

Registered

2025-09-17

Start date

2025-09-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood disorders

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who have provided informed consent to participate in this study 2.Patients aged 18 years or older with hematologic diseases 3.Patients for whom the investigator has decided to initiate ISAV treatment, or who are within 14 days of ISAV initiation

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to ISAV 2.Female patients who are pregnant or breastfeeding 3.Patients with a prior history of ISAV treatment who were intolerant to the drug or for whom it was proven ineffective against the current invasive fungal infection 4.Patients deemed unsuitable for study participation by the investigator

Design outcomes

Primary

Measure	Time frame
Survey on Real-World Use of ISAV	—

Countries

Japan

Contacts

Public ContactToyohiro Kawano

Kanto Study Group for Cell Therapy office

ksgctdc@ksgct.net042-505-4251

Outcome results